在支持抑郁症治疗方面具有潜在重要性的植物:当前趋势和研究
1Department of Vegetable and Herb Crops, Faculty of Horticulture and Landscape Architecture, University of Life Sciences in Lublin, Doświadczalna 50a, 20-280 Lublin, Poland.
Pharmaceuticals (Basel, Switzerland)
|November 27, 2024
概括
抑郁症是一种常见的精神障碍. 草药药物,如沙法兰和圣约翰.
科学领域:
- 药理学和植物化学
- 神经科学和精神病学 在
背景情况:
- 抑郁症是全球普遍存在的精神健康障碍,严重影响个人福祉和社会生产力.
- 传统的抗抑郁药物往往会产生许多不良影响,引发人们对替代治疗策略的兴趣.
- 传统上用于治疗焦虑和情绪障碍的草药正因其在抑郁症管理方面的潜力而受到越来越多的关注.
研究的目的:
- 审查关于药用植物在治疗抑郁症方面的疗效的科学文献.
- 探索植物化合物在缓解抑郁症状方面的潜在作用机制.
- 突出有前途的植物物种进行进一步的研究和临床应用治疗抑郁和焦虑.
主要方法:
- 对用于抑郁症的药用植物的临床试验和植物化学研究的文献综述.
- 分析二次代谢产物及其在这些植物的神经生物学效应中所扮演的角色.
- 评估与神经保护有关的植物物质的抗氧化和抗炎性质.
主要成果:
- 某些植物材料的适应性特性与它们的二次代谢物有关,包括类,类,葡萄糖酸盐和.
- 植物化合物的抗氧化和抗炎作用可能提供神经保护性益处.
- 撒法兰 (Crocus L.),黄 (Curcuma L.),金刚果 (Ginkgo L.),圣约翰草 (Hypericum L.) 和激情花 (Passiflora L.) 显示出显著的前景.
结论:
- 药用植物具有广泛的生物活性和使用历史,支持它们在治疗抑郁和焦虑方面的作用.
- 神经细胞保护作用,归因于抗氧化和抗炎性质,是它们治疗潜力的关键.
- 进一步的生物化学和植物制药研究是有必要的,以充分阐明和利用这些有前途的植物药物的好处.
相关概念视频
Antidepressant Drugs: MAOIs and Other Agents
194
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
194
Depression: Overview
216
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
216
Antidepressant Drugs: Overview
360
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
360
Depressive Disorders: Etiology
49
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
49
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
309
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
309
Electroconvulsive Therapy
25
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
25


